No photo of Dennis P West

View Scopus Profile

Dennis P West

  • 5767 Citations
1977 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dermatopharmacology

Training Experience

1968Residency, University of Chicago

Education/Academic qualification

PhD, Pacific Western University

… → 1993

Keywords

  • Clinical Pharmacology
  • Clinical Trial Methodology
  • Dermatology
  • Drug Discovery
  • Drugs (clinical pharmacology)
  • Pharmacology
  • Pharmacovigilance
  • Quality of Life

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
Skin Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Minoxidil Medicine & Life Sciences
Psoriasis Medicine & Life Sciences
United States Food and Drug Administration Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2022

Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

Miller, S. D., West, D. P. & Lu, K.

National Institute of Arthritis and Musculoskeletal and Skin Diseases

8/1/18 → 7/31/22

Project: Research project

Drug Repositioning
Mustard Plant
Skin
Spironolactone
Diphosphonates

Prot# P10-023: A 10-Year, Post-Marketing, Observational, Registry of HUMIRA (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (Ps)

Laumann, A. E. & West, D. P.

United BioSource LLC, Abbott Laboratories

4/20/09 → 8/31/19

Project: Research project

EHR Anticoagulants Pharmacovigilance

Belknap, S. M. & West, D. P.

University of Massachusetts Lowell, National Heart, Lung, and Blood Institute

1/22/18 → 11/30/18

Project: Research project

Data warehouses
Industry

Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

Miller, S. D. & West, D. P.

Case Western Reserve University, National Institute of Arthritis and Musculoskeletal and Skin Diseases

8/4/17 → 7/31/18

Project: Research project

Drug Repositioning
Mustard Plant
Animal Models
Pharmaceutical Preparations
Allergy and Immunology

SHF: Small: Collaborative Research: Designing a Programming Language for Patient-Oriented Prescriptions

Belknap, S. M., Findler, R. & West, D. P.

National Science Foundation

9/1/15 → 8/31/18

Project: Research project

Computer programming languages
Computer science
Software design
DSL
Software reliability

Research Output 1977 2019

Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Kelm, R. C., Hagstrom, E. L., Mathieu, R. J., Orrell, K. A., Serrano, L., Mueller, K. A., Laumann, A. E., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 820-821 2 p.

Research output: Contribution to journal › Article

Drug-Related Side Effects and Adverse Reactions
Melanoma
Research
Natalizumab

Reply to: “Aspirin use and the risk of malignant melanoma”

Orrell, K. A., Rademaker, A. W., West, D. P. & Nardone, B., Jan 1 2019, In : Journal of the American Academy of Dermatology. 80, 1, p. e15

Research output: Contribution to journal › Letter

Aspirin
Melanoma

Vulvar cancer association with groin hidradenitis suppurativa: A large, urban, midwestern US patient population study

Rastogi, S., Patel, K. R., Singam, V., Ali, Y., Gao, J., Amin, A. Z., Schlosser, B. J., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 808-810 3 p.

Research output: Contribution to journal › Article

Hidradenitis Suppurativa
Vulvar Neoplasms
Groin
Population

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journal › Editorial

Pancreatitis
Population
blinatumomab
4 Citations (Scopus)

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry

Siegfried, E. C., Jaworski, J. C., Eichenfield, L. F., Paller, A., Hebert, A. A., Simpson, E. L., Altman, E., Arena, C., Blauvelt, A., Block, J., Boguniewicz, M., Chen, S., Cordoro, K., Hanna, D., Horii, K., Hultsch, T., Lee, J., Leung, D. Y., Lio, P. A., Milner, J. & 13 othersOmachi, T., Schneider, C., Schneider, L., Sidbury, R., Smith, T., Sugarman, J., Taha, S., Tofte, S., Tollefson, M., Tom, W. L., West, D. P., Whitney, L. & Zane, L., May 1 2018, In : Pediatric Dermatology. 35, 3, p. 303-322 20 p.

Research output: Contribution to journal › Article

Atopic Dermatitis
Industry
United States Food and Drug Administration
Clinical Trials
Pharmaceutical Preparations